within Pharmacolibrary.Drugs.ATC.A;

model A06AC06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 2000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A06AC06</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Methylcellulose is a semi-synthetic, inert, hydrophilic compound derived from cellulose. It is used primarily as a bulk-forming laxative to treat constipation and to promote regular bowel movements. Methylcellulose is currently approved and in widespread clinical use as an over-the-counter oral laxative. It is also used as a food additive and in pharmaceutical formulations as a thickener or emulsifier.</p><h4>Pharmacokinetics</h4><p>No relevant pharmacokinetic (PK) studies in humans reporting systemic absorption or standard PK parameters (such as volume of distribution, clearance, or bioavailability), since methylcellulose is recognized as not systemically absorbed in the gastrointestinal (GI) tract when administered orally as a laxative. All parameters estimated based on its clinical pharmacology and non-absorption.</p><h4>References</h4><ol><li><p>Bonetti, L, Caprioglio, A, Bono, N, Candiani, G, &amp; Altomare, L (2023). Mucoadhesive chitosan-methylcellulose oral patches for the treatment of local mouth bacterial infections. <i>Biomaterials science</i> 11(8) 2699–2710. DOI:<a href=&quot;https://doi.org/10.1039/d2bm01540d&quot;>10.1039/d2bm01540d</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36722890/&quot;>https://pubmed.ncbi.nlm.nih.gov/36722890</a></p></li><li><p>Bialik, M, Kuras, M, Sobczak, M, &amp; Oledzka, E (2021). Achievements in Thermosensitive Gelling Systems for Rectal Administration. <i>International journal of molecular sciences</i> 22(11) –. DOI:<a href=&quot;https://doi.org/10.3390/ijms22115500&quot;>10.3390/ijms22115500</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34071110/&quot;>https://pubmed.ncbi.nlm.nih.gov/34071110</a></p></li><li><p>Pai, MP, Bruce, H, &amp; Felton, LA (2010). Clinical pharmacokinetics of oral controlled-release 5-fluorocytosine. <i>Antimicrobial agents and chemotherapy</i> 54(3) 1237–1241. DOI:<a href=&quot;https://doi.org/10.1128/AAC.01103-09&quot;>10.1128/AAC.01103-09</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/20038612/&quot;>https://pubmed.ncbi.nlm.nih.gov/20038612</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A06AC06;
